- Home
- RLAY vs VEON Comparison
RLAY vs VEON Comparison
Compare RLAY & VEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RLAY | VEON |
|---|---|---|
| Founded | 2015 | 1992 |
| Country | United States | United Arab Emirates |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 4.2B |
| IPO Year | 2020 | 2010 |
Fundamental Metrics
Financial Performance| Metric | RLAY | VEON |
|---|---|---|
| Price | $17.98 | $72.15 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 5 |
| Target Price | $19.50 | ★ $73.40 |
| AVG Volume (30 Days) | ★ 2.9M | 136.8K |
| Earning Date | 05-05-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 31.78 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $15,355,000.00 | N/A |
| Revenue This Year | N/A | $12.21 |
| Revenue Next Year | $324.03 | $1.60 |
| P/E Ratio | ★ N/A | $6.15 |
| Revenue Growth | ★ 53.44 | N/A |
| 52 Week Low | $5.17 | $42.60 |
| 52 Week High | $21.27 | $75.00 |
Technical Indicators
Market Signals| Indicator | RLAY | VEON |
|---|---|---|
| Relative Strength Index (RSI) | 43.01 | 66.34 |
| Support Level | $11.68 | $50.12 |
| Resistance Level | $20.29 | N/A |
| Average True Range (ATR) | 0.83 | 2.66 |
| MACD | -0.11 | -0.03 |
| Stochastic Oscillator | 34.28 | 75.23 |
Price Performance
Historical ComparisonAbout RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.
About VEON VEON Ltd. ADS
VEON Ltd is a United Arab Emirates-based digital operator providing connectivity and Internet services to corporations and individuals. The company offers mobile and fixed-line telecommunications services through a range of traditional and broadband mobile technologies. The company's reportable segments consist of the following five segments: Pakistan, Ukraine, Kazakhstan, Bangladesh, and Uzbekistan. It provides its services under the Beeline, Kyivstar, Banglalink, and Jazz brands. It generates the majority of its revenue from Pakistan. Its telecommunications and digital services include voice, fixed broadband, data and cloud services.